Barbara J Sahakian Selected Research

Barbara J Sahakian Research Topics

Disease

26	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2023 - 01/2003
14	Schizophrenia (Dementia Praecox) 01/2022 - 07/2004
11	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2003
10	Cognitive Dysfunction 10/2023 - 08/2003
9	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2002
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2024 - 05/2012
4	Substance-Related Disorders (Drug Abuse) 11/2023 - 11/2005
4	Psychotic Disorders (Schizoaffective Disorder) 01/2023 - 03/2011
4	Autism Spectrum Disorder 01/2022 - 01/2020
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 01/2018
4	Gambling (Pathological Gambling) 01/2022 - 07/2004
4	Huntington Disease (Huntington's Disease) 01/2020 - 05/2003
3	Major Depressive Disorder (Major Depressive Disorders) 12/2021 - 11/2013
3	Opioid-Related Disorders (Opiate Addiction) 01/2018 - 05/2006
3	Disease Progression 01/2018 - 12/2010
3	Depressive Disorder (Melancholia) 12/2015 - 01/2004
2	Dementia (Dementias) 07/2022 - 01/2018
2	Autistic Disorder (Autism) 01/2022 - 01/2020
2	Mental Disorders (Mental Disorder) 12/2021 - 10/2017
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 12/2015
2	Alcoholism (Alcohol Abuse) 01/2019 - 01/2018
2	Neurobehavioral Manifestations 10/2017 - 04/2015
2	Fatigue 03/2017 - 11/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2013 - 11/2008
2	Mood Disorders (Mood Disorder) 01/2012 - 08/2007
2	Trichotillomania 12/2010 - 12/2006
1	Tobacco Use Disorder (Nicotine Dependence) 01/2023
1	Neoplasms (Cancer) 07/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	dopamine beta hydroxylase deficiency 01/2022
1	Vision Disorders (Hemeralopia) 01/2022
1	Consciousness Disorders 01/2021
1	Stroke (Strokes) 01/2021
1	Weight Gain 10/2020
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017
1	Anxiety Disorders (Anxiety Disorder) 01/2017
1	Social Phobia 10/2014
1	Atrophy 06/2013
1	Meningoencephalitis 04/2013

Drug/Important Bio-Agent (IBA)

19	Methylphenidate (Ritalin)FDA LinkGeneric 01/2024 - 08/2003
13	Modafinil (Provigil)FDA Link 03/2017 - 01/2003
11	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2003
9	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2016 - 07/2007
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2011
7	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 04/2005
5	Serotonin (5 Hydroxytryptamine)IBA 12/2021 - 04/2005
4	Bumetanide (Bumex)FDA LinkGeneric 01/2022 - 01/2020
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 03/2011
4	Amphetamine (Amfetamine)FDA LinkGeneric 09/2007 - 05/2004
3	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 01/2020
3	Nootropic Agents (Nootropics)IBA 10/2017 - 07/2004
2	Indicators and Reagents (Reagents)IBA 01/2023 - 07/2022
2	Capsules (Microcapsules)IBA 01/2022 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 02/2020 - 01/2020
2	Naltrexone (ReVia)FDA LinkGeneric 01/2019 - 01/2018
2	Citalopram FDA LinkGeneric 03/2016 - 04/2014
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2015 - 04/2015
2	Wakefulness-Promoting AgentsIBA 03/2012 - 03/2011
2	Tryptophan (L-Tryptophan)FDA Link 01/2012 - 07/2004
2	CatecholaminesIBA 06/2011 - 02/2004
2	Serotonin and Noradrenaline Reuptake InhibitorsIBA 04/2009 - 11/2007
2	Tyrosine (L-Tyrosine)FDA Link 04/2005 - 01/2004
1	Cocaine (Cocaine HCl)IBA 11/2023
1	Escitalopram FDA Link 10/2023
1	Opioid Receptors (Opioid Receptor)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 07/2022
1	CytokinesIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	InterferonsIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 12/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Muscarinic M1 ReceptorIBA 01/2020
1	Biperiden (Akineton)FDA Link 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	Psychotropic Drugs (Psychoactive Drugs)IBA 10/2017
1	Insulin (Novolin)FDA Link 03/2017
1	N 30IBA 03/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	Serotonin AgentsIBA 03/2016
1	GlucocorticoidsIBA 12/2015
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 10/2014
1	Therapeutic UsesIBA 11/2013
1	AutoreceptorsIBA 11/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 05/2004
4	Cognitive Training 01/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
3	Behavior Control 10/2020 - 12/2007
1	Transcranial Direct Current Stimulation 12/2021
1	Precision Medicine 12/2021
1	Neurological Rehabilitation 01/2021
1	Deep Brain Stimulation 01/2019
1	Secondary Prevention 01/2018
1	Ambulatory Care (Outpatient Care) 01/2017
1	Transplantation 06/2013
1	Cell Transplantation 06/2013